StockDriftsStockDriftsTop 14 Sr One Capital Management, Lp Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ACLX | Arcellx, Inc. | 29.43% | 2.35M | $269.4M | +0.00%(+0) | $14.02(+720.76%) | 2026-03-31 | |
| MANE | Veradermics, Inc. | 16.57% | 2.40M | $151.7M | new | $63.15(+105.45%) | 2026-03-31 | |
| ZBIO | Zenas BioPharma, Inc | 10.76% | 5.04M | $98.5M | +0.00%(+0) | $17.23(+6.45%) | 2026-03-31 | |
| CRSP | CRISPR Therapeutics AG | 10.59% | 2.04M | $97.0M | +0.00%(+0) | $61.18(-1.79%) | 2026-03-31 | |
| DSGN | Design Therapeutics, Inc. | 7.59% | 6.53M | $69.4M | +0.00%(+0) | $17.42(-10.22%) | 2026-03-31 | |
| ORIC | ORIC Pharmaceuticals, Inc. | 6.39% | 4.51M | $58.5M | +0.00%(+0) | $8.14(+42.91%) | 2026-03-31 | |
| ALMS | Alumis Inc. | 4.72% | 1.96M | $43.2M | +0.00%(+0) | $13.30(+99.25%) | 2026-03-31 | |
| MLYS | Mineralys Therapeutics Inc. | 4.63% | 1.56M | $42.4M | +0.00%(+0) | $14.76(+87.66%) | 2026-03-31 | |
| SPRY | ARS Pharmaceuticals, Inc. | 3.52% | 4.01M | $32.2M | +0.00%(+0) | $7.06(+21.27%) | 2026-03-31 | |
| ORKA | Oruka Therapeutics, Inc | 2.31% | 430.3K | $21.1M | +0.00%(+0) | $33.54(+154.08%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +5.57% | +17.64% |
| Top 20 Holdings Unweighted | +35.36% | +148.04% |
Sign up free to track Sr One Capital Management, Lp, compare funds side by side, and get alerts the moment positions change.